July 24, 2018
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: ProQR develops RNA treatments aimed at rare diseases
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
VANCOUVER, British Columbia ― Daniel de Boer, CEO of ProQR, discusses the company’s ophthalmology pipeline, including QR-110 for Leber’s congenital amaurosis type 10 presented during the Foundation Fighting Blindness Emerging Science Showcase at OIS Retina.